AB219. SOH26AB_0183. Hormone replacement therapy and breast cancer trends: a case-control study insight
Mesentery and Peritoneum · 2026-04 · 10 · AB219-AB219
DOI: 10.21037/map-26-ab219 ↗Kurz gefasst
Fall-Kontroll-Studie in der Zeitschrift Mesentery and Peritoneum, 2026-04. Verfasst von Mohamed Ismaiel und 9 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Ismaiel, M., Beattie, E., Majeremane, W., Corcoran, S., Ramkaran, C., Keohane, C., Buckley, J., Tormey, S., Merrigan, A., & Baban, C. (2026). AB219. SOH26AB_0183. Hormone replacement therapy and breast cancer trends: a case-control study insight. Mesentery and Peritoneum, 10, AB219-AB219. https://doi.org/10.21037/map-26-ab219
Vancouver
Ismaiel M, Beattie E, Majeremane W, Corcoran S, Ramkaran C, Keohane C, et al. AB219. SOH26AB_0183. Hormone replacement therapy and breast cancer trends: a case-control study insight. Mesentery and Peritoneum. 2026;10:AB219-AB219. doi:10.21037/map-26-ab219
BibTeX
@article{Ismaiel2026,
author = {Ismaiel, Mohamed and Beattie, Eibhlin and Majeremane, Wame and Corcoran, Sinead and Ramkaran, Chrisen and Keohane, Claire and Buckley, Juliette and Tormey, Shona and Merrigan, Anne and Baban, Chwanrow},
title = {AB219. SOH26AB_0183. Hormone replacement therapy and breast cancer trends: a case-control study insight},
journal = {Mesentery and Peritoneum},
year = {2026},
volume = {10},
pages = {AB219--AB219},
doi = {10.21037/map-26-ab219}
}
EUVIMED